You are here

obesity

MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup

BioPharma Dive

Thu, 03/13/25 - 11:25 pm

Parkinson's Disease

Asceletis’ muscle-preserving weight loss therapy sustains 40-day half-life

Clinical Trials Arena

Wed, 03/12/25 - 11:18 pm

Harbour BioMed launches new obesity biotech on mission to preserve muscle mass

Fierce Biotech

Wed, 03/12/25 - 11:21 am

bispecific antibodies

Élancé Therapeutics

Roche builds in obesity with $5.3bn Zealand licensing deal

Pharmaphorum

Wed, 03/12/25 - 11:09 am

Viking secures 1b supply of obesity pill candidate with $150m prepayment deal

BioSpace

Tue, 03/11/25 - 11:32 am

Viking Therapeutics

Novo Nordisk's Ozempic successor disappointed Wall Street again

Yahoo Finance

Mon, 03/10/25 - 11:13 am

clinical trials

In FDA obesity drug battle with compounders, Texas court allows Novo Nordisk to weigh in

Fierce Pharma

Thu, 03/6/25 - 11:02 am

drug compounding

Amgen enters Maritime, launching 2 late-stage obesity trials for MariTide

Fierce Biotech

Wed, 03/5/25 - 10:58 pm

clinical trials

AbbVie pays Gubra $350M to make late play for obesity space

Fierce Biotech

Mon, 03/3/25 - 11:02 am

India's Sun Pharma aims to launch its obesity drug in five years, managing director says

MSN/Reuters

Mon, 03/3/25 - 10:11 am

Where Will Eli Lilly Be in 5 Years?

Motley Fool

Sun, 03/2/25 - 09:41 pm

ulcerative colitis

As Money Pours Into Weight Loss Drugs, Physicians Prioritize Efficacy, Access

BioSpace

Thu, 02/27/25 - 11:18 am

Kallyope links oral obesity combo to 3% weight loss, rejigs pipeline as migraine asset advances

Fierce Biotech

Thu, 02/27/25 - 11:09 am

clinical trials

Its CEO died. The company scrapped a promising program. Now, for their 2nd act.

Pharma Voice

Thu, 02/27/25 - 10:12 am

Terns Pharmaceuticals

Eli Lilly Bets Big on Weight-Loss Pill With $550 Million Inventory Stockpile

US News and World Report

Thu, 02/20/25 - 06:07 pm

clinical trials

Insurers push back on Medicare and Medicaid coverage for GLP-1s

Axios

Thu, 02/20/25 - 11:37 am

Ascletis' swift surge into obesity continues with competitive oral GLP-1 data

Fierce Biotech

Wed, 02/19/25 - 09:47 pm

Ascletis Pharma

clinical trials

Wegovy and Ozempic stars dim amid overuse concerns

Axios

Tue, 02/11/25 - 11:17 am

Novo Nordisk plans new study for CagriSema, targets 2026 submission

Clinical Trials Arena

Fri, 02/7/25 - 11:42 am

clinical trials

Amgen's early-stage obesity asset slapped with FDA hold

Fierce Biotech

Wed, 02/5/25 - 11:27 am

clinical trials

Pages